Overview
Diversified Healthcare Trust is a real estate investment trust based in the United States, specifically focused on owning and managing healthcare-related properties. Primarily operating within the healthcare sector, its portfolio comprises properties across various categories including medical office buildings, inpatient rehabilitation hospitals, and life science properties. The trust’s strategy is centered on leveraging the growing demand for healthcare infrastructure by acquiring, developing, and managing facilities in high-growth areas. Key projects include strategic redevelopments and enhancements aimed at boosting facility value and attractability to tenants, particularly in high-tech and high-potential markets. Diversified Healthcare Trust's investment approach underpins its mission to provide well-maintained and strategically located healthcare facilities that meet the evolving needs of its tenants and their patients.
Basic Stats
The share price of Diversified Healthcare Trust as of September 4, 2025 is $3.89 / share. This is an increase of 3.18% from the prior week. The market cap (or net worth) of Diversified Healthcare Trust as of September 4, 2025 is $937.92 MM.
The Factor Analysis chart (below right) shows a view of Diversified Healthcare Trust from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 937.92 MM |
| EV | 3,431.17 MM |
| Shares Out. | 241.42 MM |
| Earnings Date | |
| EPS (TTM) | -1.19 |
| Dividend Yield | 1.03 % |
| Ex-Dividend Date | 2025-07-21 |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 2.40 MM |
| Short Interest | 5.21 MM |
| Short Float | 2.80 % |
| Days to Cover | 12.95 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | 18.09 % |
| Volatility (1 yr) | 0.61 |
| Beta | 0.44 |
| Sharpe Ratio (1 yr) | 0.23 |
| Sortino Ratio (1 yr) | 0.42 |
| PE Ratio | -3.27 |
| Price/Book | 0.51 |
| Price/TBV | 0.51 |
| Book/Market | 1.98 |
| EBIT/EV | -0.08 |
| EBIT(3yr avg)/EV | -0.09 |
| ROA | -0.05 |
| ROE | -0.13 |
| ROIC | -0.06 |
| CROIC | -0.03 |
| OCROIC | 0.02 |
| Implied Volatility | 131.23 % |
| Put/Call OI Ratio | 0.46 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Diversified Healthcare Trust is $3.82. The forecasts range from a low of $3.03 to a high of $4.72. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Diversified Healthcare Trust. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2021-12-30 | B. Riley Securities | Buy | Maintains | |
| 2021-07-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-03-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-02-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-16 | B of A Securities | Underperform | Maintains | |
| 2020-10-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-06-22 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-06-08 | JMP Securities | Market Perform | Reiterate | |
| 2020-05-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-05-11 | B. Riley FBR | Buy | Maintains | |
| 2020-03-04 | B. Riley FBR | Buy | Maintains | |
| 2020-01-17 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2020-01-07 | Raymond James | Underperform | Market Perform | Upgrade |
| 2019-10-14 | Bank of America | Underperform | Initiate | |
| 2019-04-03 | RBC Capital | Sector Perform | Underperform | Downgrade |
| 2018-12-03 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2018-11-16 | Jefferies | Hold | Underperform | Downgrade |
| 2018-11-12 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-10-30 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2018-08-08 | B. Riley FBR | Buy | Buy | Maintains |
| 2018-03-20 | Wells Fargo | Underperform | Underperform | Maintains |
| 2018-03-08 | Bank of America | Underperform | Underperform | Maintains |
| 2018-02-28 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2017-10-02 | UBS | Neutral | Maintains | |
| 2017-09-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-05-15 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2017-03-09 | Baird | Neutral | Initiate | |
| 2016-12-29 | Cantor Fitzgerald | Overweight | Initiate | |
| 2016-12-13 | Wells Fargo | Market Perform | Underperform | Downgrade |
| 2016-10-20 | Jefferies | Buy | Hold | Downgrade |
| 2016-08-22 | Jefferies | Buy | Maintains | |
| 2016-06-17 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2015-10-22 | Wells Fargo | Underperform | Market Perform | Upgrade |
| 2015-10-08 | FBR Capital | Market Perform | Initiate | |
| 2015-06-18 | UBS | Sell | Neutral | Upgrade |
| 2015-06-08 | Jefferies | Hold | Maintains | |
| 2014-08-13 | Jefferies | Hold | Maintains | |
| 2014-02-12 | UBS | Neutral | Sell | Downgrade |
| 2014-01-07 | Wells Fargo | Market Perform | Underperform | Downgrade |
| 2013-09-10 | Janney Capital | Neutral | Initiate | |
| 2013-02-19 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2013-01-11 | Sandler O'Neill | Buy | Hold | Downgrade |
| 2013-01-08 | Jefferies | Buy | Hold | Downgrade |
| 2012-11-09 | Jefferies | Buy | Maintains | |
| 2012-09-26 | Jefferies | Buy | Maintains | |
| 2012-07-16 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2023-09-05 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-08-05 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-10-14 | RBC Capital | Underperform | Underperform | Maintains |
| 2024-08-21 | JMP Securities | Market Perform | Reiterate |
